Free Trial
ASX:RCE

Recce Pharmaceuticals (RCE) Stock Price, News & Analysis

Recce Pharmaceuticals logo

About Recce Pharmaceuticals Stock (ASX:RCE)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
630,087 shs
Average Volume
N/A
Market Capitalization
A$104.34 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive RCE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Recce Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

RCE Stock News Headlines

Is Elon's empire crumbling?
The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as July 23rd.
See More Headlines

RCE Stock Analysis - Frequently Asked Questions

Recce Pharmaceuticals Ltd (ASX:RCE) released its quarterly earnings results on Wednesday, February, 27th. The company reported ($0.01) earnings per share (EPS) for the quarter. Recce Pharmaceuticals had a positive trailing twelve-month return on equity of 392.94% and a negative net margin of 741.65%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Recce Pharmaceuticals investors own include ASE Technology (ASX), FlexiGroup Limited (FXL.AX) (FXL), Prima BioMed (IMMP), Mavenir (MVNR), Cronos Group (CRON), Cree (CREE) and Caladrius Biosciences (CLBS).

Company Calendar

Last Earnings
2/27/2019
Today
7/09/2025

Industry, Sector and Symbol

Stock Exchange
ASX
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
ASX:RCE
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-A$17.66 million
Net Margins
-741.65%
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
A$5.03 million
Price / Cash Flow
13.57
Book Value
A($0.05) per share
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
A$104.34 million
Optionable
Not Optionable
Beta
1.05
7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

This page (ASX:RCE) was last updated on 7/9/2025 by MarketBeat.com Staff
From Our Partners